Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Markowitz

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2009
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACHWallace Crandall, Jeffrey Hyams, Subra Kugathasan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2011
Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitisJeffrey Hyams, Lakshmi Damaraju, Marion Blank, et al.
Gastroenterology|February 28, 2007
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in childrenJeffrey Hyams, Wallace Crandall, Subra Kugathasan, et al.
Current Medical Research and Opinion|January 19, 2011
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extensionJeffrey Hyams, Thomas D Walters, Wallace Crandall, et al.
Inflammatory Bowel Diseases|February 9, 2007
Intercenter variation in initial management of children with Crohn's diseaseMichael D Kappelman, Athos Bousvaros, Jeffrey Hyams, et al.
Gastroenterology|May 8, 2012
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in childrenJeffrey S Hyams, Anne Griffiths, James Markowitz, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2025
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre StudyRonen Stein, Dan Turner, Séamus Hussey, et al.
Nature Communications|June 29, 2021
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screenSanam Soomro, Suresh Venkateswaran, Kamala Vanarsa, et al.
Inflammatory Bowel Diseases|December 25, 2008
Long-term outcome of maintenance infliximab therapy in children with Crohn's diseaseJeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Gastroenterology|March 3, 2010
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of responseDan Turner, David Mack, Neal Leleiko, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2009
Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACHWallace Crandall, Jeffrey Hyams, Subra Kugathasan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2011
Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitisJeffrey Hyams, Lakshmi Damaraju, Marion Blank, et al.
Gastroenterology|February 28, 2007
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in childrenJeffrey Hyams, Wallace Crandall, Subra Kugathasan, et al.
Current Medical Research and Opinion|January 19, 2011
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extensionJeffrey Hyams, Thomas D Walters, Wallace Crandall, et al.
Inflammatory Bowel Diseases|February 9, 2007
Intercenter variation in initial management of children with Crohn's diseaseMichael D Kappelman, Athos Bousvaros, Jeffrey Hyams, et al.
Gastroenterology|May 8, 2012
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in childrenJeffrey S Hyams, Anne Griffiths, James Markowitz, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2025
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre StudyRonen Stein, Dan Turner, Séamus Hussey, et al.
Nature Communications|June 29, 2021
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screenSanam Soomro, Suresh Venkateswaran, Kamala Vanarsa, et al.
Inflammatory Bowel Diseases|December 25, 2008
Long-term outcome of maintenance infliximab therapy in children with Crohn's diseaseJeffrey S Hyams, Trudy Lerer, Anne Griffiths, et al.
Gastroenterology|March 3, 2010
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of responseDan Turner, David Mack, Neal Leleiko, et al.
Pageof 10